Metraipolis › archive › dc_3ce24813fa20

Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety — Europe PMC PMID:40904688

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40904688
DOI
10.34133/hds.0325
License (as archived)
solo-consultazione
Archived
2026-11-10T04:48:59.653Z
SHA-256 of the archived text
b69db656853945ce4d7fd6f0725ef450e8bde25e7aee01f074ad73aeef11e245
Stable URL of this page
https://metraipolis.com/documento/dc_3ce24813fa20

How to cite

Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety — Europe PMC PMID:40904688 — Europe PMC (en), https://europepmc.org/article/MED/40904688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ce24813fa20 (Metraipolis archive dc_3ce24813fa20, sha256 b69db656853945ce4d7fd6f0725ef450e8bde25e7aee01f074ad73aeef11e245)
BibTeX
@misc{dc3ce24813fa20,
  title = {Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety — Europe PMC PMID:40904688},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40904688},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ce24813fa20; sha256 b69db656853945ce4d7fd6f0725ef450e8bde25e7aee01f074ad73aeef11e245},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40904688. Agents can read the archived copy with the MCP tool read_document.